Venture Capital

As Flex heads to a key investor conference, a look at its record financials and pivotal role in building the high-stakes infrastructure for the AI era.

BioNexus Gene Lab appoints Matthew Barsing to lead its Chemrex subsidiary, signaling a strategic overhaul from industrial chemicals to biotech and advanced tech.

A new summit reveals the high-stakes, collaborative effort to build the open standards that will move AI agents from futuristic demos to enterprise reality.

Recursion, HighRes, and NVIDIA are pioneering automated drug discovery. Inside the 'Physical AI' revolution poised to radically accelerate the hunt for new cures.

With its stock under pressure, Geron will face investors to defend its RYTELO sales strategy and address delays in its pivotal myelofibrosis trial.

As Lyell presents at three major investor conferences, the biotech's pipeline, financial health, and future in cancer therapy are under scrutiny.

With a $2.5B valuation and new brand, Mews is betting its unified platform can solve hospitality's biggest problems: fragmentation and inefficiency.

The Biocodex Microbiota Foundation opens its 10th annual grant, committing a total of half a million dollars to shape the future of U.S. gut health science.

With a new CEO known for commercial turnarounds, oneworld signals a strategic push for tech integration, customer value, and competitive growth.

With its lead CAR-T therapy, Descartes-08, in late-stage trials, Cartesian Therapeutics is set to update investors on its pioneering work in autoimmune disease.

With a soaring stock, $300M in new funding, and strong clinical data, Monte Rosa is set to showcase its novel disease-fighting drug platform.

New 12- and 24-month data for Benitec Biopharma's BB-301 gene therapy offers renewed hope for patients with a rare, debilitating muscular dystrophy.

With a key drug in trials and a pipeline nearing the clinic, Foghorn Therapeutics brings in a seasoned financial leader to navigate its path to market.

Armed with $320M in new capital, Anteris will showcase its revolutionary biomimetic heart valve to top investors. Can it disrupt a market of giants?

An updated study reveals a massive jump in value for the Angel Island lithium project, driven by breakthrough processing tech and slashed operating costs.

With its stock under pressure despite strong results, Box will use a key conference to prove its AI-powered content platform is the future of enterprise work.

Surge Copper’s massive Berg Project gets key provincial support, aiming to streamline development and secure Canada's role in the global critical minerals race.

At a massive festival, an AI avatar of yogi Sadhguru offered guidance via hologram, merging ancient wisdom with futuristic tech. But what does this mean?

Mobile gaming giant AviaGames partners with UC San Diego MBA students to analyze its hit game, Solitaire Clash, seeking a data-driven edge in a competitive market.

Korean brand Laka brings its gender-neutral philosophy to Sephora, betting that US consumers are ready for beauty without rigid rules or boundaries.